Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Uterine Cancer
Estrogen for Survivors of Uterine Cancer? A New Study Will Resolve Debate
May 26th, 1997
The first large, national study of estrogen replacement therapy (ERT) for women who have had cancer of the uterus will start enrolling patients this summer, researchers announced at the annual meeting of The American College of Obstetricians and Gynecologists (ACOG) in Las Vegas. The study is designed to resolve the current controversy over the safety of estrogen replacement for survivors of uterine, or endometrial, cancer. The ERT Study is being sponsored by the National Cancer Institute (NCI) and organized by the Gynecologic Oncology Group (GOG), a program of ACOG. GOG is one of 11 cooperative trial groups -- networks of medical centers that...
Source: Cancer Weekly (1997-05-26)
|
